Navigation Links
EntreMed Receives Notice of NASDAQ Compliance
Date:10/15/2010

ROCKVILLE, Md., Oct. 15 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum $35 million Market Value of Listed Securities ("MVLS") requirement for continued listing on the NASDAQ Capital Market as set forth in NASDAQ Marketplace Rule 5550(b)(2).(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO)

On August 17, the Company received a Staff Determination Letter from NASDAQ stating that it was not in compliance with the rule because its MVLS failed to meet the required $35 million minimum for the last 30 consecutive business days.  At that time, the Company was granted 180 calendar days, or until February 14, 2011, to regain compliance with the rule.  

In order to regain compliance, the Company was required to maintain a $35 million MVLS for a minimum of 10 consecutive business days.  In its October 13, 2010 notification, NASDAQ provided written confirmation that EntreMed has regained compliance with the rule and that this matter is now closed.

About EntreMedEntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking StatementsThis release contains forward-looking
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... DUBLIN , April 23, 2015  Jazz Pharmaceuticals ... will report its 2015 first quarter financial results on ... financial markets.  Company management will host a live audio ... p.m. IST to discuss first quarter 2015 financial results ... Interested parties may access the live audio webcast via ...
(Date:4/23/2015)... Colo. , Apr. 23, 2015 Surna, ... manufactures, and distributes state-of-the art equipment and systems ... in commercial indoor cannabis cultivation, will host a ... Monday, April 27, 2015, at 4:15 PM Eastern ... The conference call will be listen-in only, ...
(Date:4/23/2015)... 2015 Holographic Optical Technologies, innovator in ... Voxgram hologram technology available to the consumer market ... https://www.kickstarter.com/projects/629071847/holographic-optical-technologies?ref=nav_search The company is ... the eight-inch Voxbox hologram viewer. This product is ... established, medical-grade unit, the Voxbox Pro. ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3Holographic Optical Technologies Launches Kickstarter, Offering True 3D Holograms 2
... Pa., Jan. 4, 2012  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) ... 30th Annual J.P. Morgan Healthcare Conference to be held ... in San Francisco, CA.  Mr. Adrian Adams, Chief Executive ... of the Company and its product pipeline at 2:00 ...
... /PRNewswire-iReach/ -- DFH Pharma, Inc., (DFH) ... in the HIV-1 therapeutic space, announced today the ... services to support DFH efforts to develop the ... inhibitors are a novel class of antiretroviral drug ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 3Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 4DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 2DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 3
(Date:4/24/2015)... Multi Customer Discount , Rules: This special ... ) of 1000-1500 gallons in Zeiter's Septics service area. ... not include any Dig fees, or any other fees, ... someone is part of this group event and has ... gallons or more, the cost would be $300.00. These ...
(Date:4/24/2015)... Ryadon is a leading manufacturer of custom ... services to complement any custom hardware requirements you may ... be offered on all heavy duty drawer slides ( ... discount - Order 20+: Receive 20% discount , Industries ... Furniture ,Drawer Slides, Inc. ...
(Date:4/24/2015)... The Fastest Fat Loss Week Ever, released by ... the Xtreme Fat Loss Diet, has been causing a lot ... that claims to help one lose belly fat in only ... prompting an investigative review. , "Our Fastest Fat Loss ... researching and experimenting with these methods on their clients with ...
(Date:4/24/2015)... Denver, CO (PRWEB) April 24, 2015 ... and have toured almost constantly across the globe to theaters, ... their home in Manchester, they’ve partnered with their label, Dirty ... need. , Teaming up with the newly launched Cadence ... first-press of their debut LP on vinyl and a signed ...
(Date:4/24/2015)... The first step to transforming one’s ... For meditation and yoga teacher Stine Koppernæs, meditation and ... tools that allow her to experience more peace and ... a teacher since 2006, and through the years she ... being. , “I love sharing this way of finding ...
Breaking Medicine News(10 mins):Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2
... June 18 Doctors in the Netherlands have developed ... using fast and precise RapidArc(TM) radiotherapy technology from Varian ... among the findings in several papers published by the ... , , Radiation oncologist Dr. Frank Lagerwaard and ...
... 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ... present at the Piper Jaffray Fourth Annual Europe Conference on ... am Eastern Time, 1:30 a.m. Pacific Time) at the Andaz ... Senior Vice President and Chief Scientific Officer, is scheduled to ...
... Md., June 18 Micromet, Inc. (Nasdaq: ... proprietary antibodies for the treatment of cancer, inflammation ... the first clinical trial for the anti-granulocyte macrophage ... collaboration partner Nycomed. , , The double-blind, ...
... ... Ovu-Trac®, an Ovulation Predictor Kit now available in the United States ... accuracy. This fertility predictor has been used successfully by tens of ... Administration requirements for legal sale in the United States. The kit allows ...
... ... scheduled to take place in Summit, NJ on September 24th and September 25th, 2009, ... developments in discovery research, preclinical development, clinical development, regulatory issues and real-world pain management ... ...
... 2007, the progress made in the 1990s and early ... pregnancy and childbearing stalled, and may even have reversed ... "Changing Behavior Risk for Pregnancy Among High School Students ... MD, MPH, professor and chair of the Heilbrunn Department ...
Cached Medicine News:Health News:Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center 2Health News:Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center 3Health News:Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 2Health News:Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 3Health News:Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203 2Health News:Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203 3Health News:Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203 4Health News:Ovu-Trac(R) Home Test Kit From OvumOptics Predicts Ovulation with 96.2% Accuracy 2Health News:Ovu-Trac(R) Home Test Kit From OvumOptics Predicts Ovulation with 96.2% Accuracy 3Health News:Ovu-Trac(R) Home Test Kit From OvumOptics Predicts Ovulation with 96.2% Accuracy 4Health News:Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit 2Health News:Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit 3Health News:Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit 4Health News:Teens are heading in wrong direction: Likely to have sex, but not use contraception 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: